Walvax Biotechnology Co. Ltd. | Cash Flow
Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
4,881.80
96,705.10
924,652.80
30,020.40
558,242.80
1,062,691.10
Depreciation, Depletion & Amortization
128,316.80
123,953.90
85,896.80
122,213.70
126,168.70
127,058.90
Other Funds
100,536.10
188,999.50
1,016,646.70
601,819.10
43,120.90
1,114,562
Funds from Operations
204,225.90
74,788.60
70,961.20
217,276.00
274,981.60
27,830.80
Changes in Working Capital
325,838.00
10,992.50
5,145.10
306,101.00
221,913.50
36,332.20
Net Operating Cash Flow
121,612.10
63,796.10
65,816.10
88,825.00
53,068.10
64,163
Capital Expenditures
389,670.60
240,393.00
264,747.80
250,236.00
331,061.70
Sale of Fixed Assets & Businesses
80.60
633,774.20
1,076.10
505,061.00
1,313,649.70
Purchase/Sale of Investments
167,900.00
9,900.00
97,125.00
20,050.80
1,000.00
Net Investing Cash Flow
1,429,249.00
252,454.80
454,756.60
310,250.80
981,588.00
Cash Dividends Paid - Total
45,558.00
9,000.00
11,700.00
-
-
Issuance/Reduction of Debt, Net
1,504,325.00
131,500.00
76,000.00
401,041.30
1,185,202.00
Net Financing Cash Flow
1,358,230.90
329,499.50
928,946.70
200,777.90
1,142,081.10
Net Change in Cash
192,630.20
645,750.40
408,373.90
422,445.20
214,138.40
Free Cash Flow
511,282.80
304,189.10
330,563.90
339,061.00
384,129.80
Deferred Taxes & Investment Tax Credit
26,869.20
1,517.40
11,619.30
17,523.50
25,955.70
103,018.90
Net Assets from Acquisitions
727,324.50
419,111.00
288,210.00
53,125.00
-
Other Sources
-
-
-
88,500.00
-
Exchange Rate Effect
-
-
-
241.40
577.20
Other Uses
144,434.50
236,625.00
-
-
-
About Walvax Biotechnology Co.
View Profile
